TENAX THERAPEUTICS, INC.

Profile

Company Names

TENAX THERAPEUTICS, INC.
OXYGEN BIOTHERAPEUTICS, INC.

Addresses

101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC 27517

ONE COPLEY PARKWAY, ONE COPLEY PARKWAY, MORRISVILLE, NC 27560

ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE, NC 27560

2530 MERIDIAN PARKWAY, 3RD FLOOR, DURHAM, NC 27713

Phone Numbers

919-855-2100
(919) 855-2100
714-427-6363

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$141,753,943.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2024-08-08 
$99,681,169.00 
$174,999,993.00 
$75,318,824.00 
Equity 
9
2022-05-17 
$8,000,000.00 
$8,000,000.00 
$0.00 
 
8
2021-07-08 
$9,999,998.00 
$9,999,998.00 
$0.00 
 
7
2020-07-08 
$5,173,587.00 
$5,173,587.00 
$0.00 
 
6
2020-03-13 
$317,167.00 
$317,167.00 
$0.00 
 
5
2013-11-13 
$6,579,122.00 
$6,579,122.00 
$0.00 
Equity 
4
2013-08-22 
$4,600,000.00 
$4,600,000.00 
$0.00 
Equity 
3
2013-07-23 
$52,900.00 
$52,900.00 
$0.00 
Equity 
2
2013-02-27 
$2,100,000.00 
$2,100,000.00 
$0.00 
Equity 
1
2009-06-08 
$5,250,000.00 
$21,000,000.00 
$15,750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JUNE 
 
ALMENOFF 
DIRECTOR
RONALD 
BLANCK 
DIRECTOR
RONALD 
R. 
BLANCK 
DIRECTOR
WILLIAM 
CHATFIELD 
DIRECTOR
WILLIAM 
A. 
CHATFIELD 
DIRECTOR
ANTHONY 
 
DITONNO 
DIRECTOR, EXECUTIVE OFFICER
ANTHONY 
DITONNO 
DIRECTOR
ANTHONY 
A. 
DITONNO 
DIRECTOR
MELVILLE 
 
ENGLE 
DIRECTOR
CHRISTOPHER 
T. 
GIORDANO 
EXECUTIVE OFFICER, DIRECTOR
LAWRENCE 
R. 
HOFFMAN 
EXECUTIVE OFFICER
ROBYN 
 
HUNTER 
DIRECTOR
ROBYN 
M. 
HUNTER 
DIRECTOR
MICHAEL 
 
JEBSEN 
EXECUTIVE OFFICER
MICHAEL 
JEBSEN 
EXECUTIVE OFFICER
MICHAEL 
B. 
JEBSEN 
EXECUTIVE OFFICER
JOHN 
 
KELLEY 
EXECUTIVE OFFICER
RICHARD 
 
KIRAL 
DIRECTOR, EXECUTIVE OFFICER
GERALD 
 
KLEIN 
DIRECTOR
ELIOT 
 
LURIER 
EXECUTIVE OFFICER
JAMES 
 
MITCHUM 
DIRECTOR
GREGORY 
 
PEPIN 
DIRECTOR
GERALD 
 
PROEHL 
DIRECTOR
CHRIS 
RALLIS 
DIRECTOR
STUART 
 
RICH 
EXECUTIVE OFFICER, DIRECTOR
CHARLES 
 
SEEMAN 
EXECUTIVE OFFICER
BRUCE 
 
SPIESS 
DIRECTOR
CHRIS 
 
STERN 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-08-08 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-05-17 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-07-08 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
 
2020-07-08 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
 
2020-03-13 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2013-11-13 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2013-08-22 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2013-07-23 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1 - $1,000,000 
Equity 
2013-02-27 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
NO REVENUES 
Equity 
2009-06-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
NONE
NONE
GUGGENHEIM SECURITIES, LLC
NONE
NONE
WILLIAM BLAIR + COMPANY, L.L.C.
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
MELIXIA SA
NONE
NONE
NONE
MTS FINANCE LTD.
NONE